Assura Plc (LON:AGR - Get Free Report) shares reached a new 52-week low during trading on Thursday . The company traded as low as GBX 37.43 ($0.47) and last traded at GBX 37.44 ($0.47), with a volume of 3327613 shares traded. The stock had previously closed at GBX 38.32 ($0.48).
Analysts Set New Price Targets
Separately, Berenberg Bank reissued a "buy" rating and issued a GBX 51 ($0.64) price target on shares of Assura in a research note on Tuesday, September 17th.
Check Out Our Latest Report on AGR
Assura Stock Down 1.6 %
The company has a market cap of £1.23 billion, a price-to-earnings ratio of -3,772.00, a price-to-earnings-growth ratio of 3.60 and a beta of 0.37. The company has a current ratio of 0.89, a quick ratio of 2.84 and a debt-to-equity ratio of 85.04. The firm's fifty day moving average price is GBX 39.70 and its 200-day moving average price is GBX 40.75.
Assura Dividend Announcement
The firm also recently declared a dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Thursday, December 12th will be given a dividend of GBX 0.84 ($0.01) per share. This represents a dividend yield of 2.12%. The ex-dividend date is Thursday, December 12th. Assura's dividend payout ratio is currently -30,000.00%.
About Assura
(
Get Free Report)
Assura plc is a national healthcare premises specialist and UK REIT based in Altrincham, UK - caring for more than 600 primary healthcare buildings, from which over six million patients are served. A constituent of the FTSE 250 and the EPRA indices, as at 30 September 2023, Assura's portfolio was valued at £2.7 billion.
Featured Stories
Before you consider Assura, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Assura wasn't on the list.
While Assura currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.